Analyzing determinants of premature trial discontinuation in leukemia clinical trials.
Rotter LK, Alhajahjeh A, Stempel JM, Grimshaw AA, Bewersdorf JP, Blaha O, Kewan T, Podoltsev NA, Shallis RM, Mendez L, Stahl M, Zeidan AM.
Rotter LK, et al. Among authors: alhajahjeh a.
Leuk Lymphoma. 2024 Oct 23:1-9. doi: 10.1080/10428194.2024.2416565. Online ahead of print.
Leuk Lymphoma. 2024.
PMID: 39440622